Diclofenac 50mg and Paracetamol Tablet 500mg

• Type: GMP
• Pharmaceutical Technology: Chemical Synthesis
• Specificate: 550mg
• Registration: Available
• OEM: Available
• Transport Package: 550mg, 1X10′s/Box
• Model NO.: AMC12035-01
• Trademark: Medipharm, OEM
• Origin: China
• HS Code: 30049090
• Production Capacity: 100000ctns Per Month

Product Description

Diclofenac + Paracetamol Tablets 550mg
 

Indications:
Management of Primary dysmenorrhoea, prompt pain relief. Non-articular Rheumatic conditions, Rheumatoid or osteo arthritis, Cervical Spondylosis, Infective inflammation A dental conditions, Pain, Fever as associated with inflammation.
Contra-indications:
Sensitivity to paracetamol. Severe liver function implement-Diclofenac potassium is contra-indicated in patients with known hypersensitivity to diclofenac and in patients who respond to aspirin and aspirin-type drugs with sensitivity reactions like asthma, acute rhinitis and urticaria. Diclofenac potassium is absolutely contra-indicated in patients with peptic ulceration or a history of such ulceration, and should be used with caution in patients with renal or hepatic.
Warnings:
Doses in excess of those recommended can cause severe liver damage.
Prolonged excessive use may cause irreversible kidney damage. Patients suffering from liver or kidney disease should only take Paracetamol under medical supervision. Consult your doctor if no relief is obtained from the recommended dosage. Do not use continuously for more than 10 days without consulting your doctor.
Dosage and directions for use:
Usual Adult Dose: 1 Tablet every 8 or 12 hours or as directed by your physician.
The recommended daily dose for in any dosage form is 3 tablets.
The product is not recommended for use in children do not use continuously for more than ten(IO) days without consulting your doctor.
Adverse Effects:
Skin rashes and other allergic reactions may occur occasionally. The rash is usually erythematous or urticarial, but sometimes more serious and may be accompanied by drug fever and mucosal lesions. The use of paracetamol has been associated with the occurrence of neutropenia, thrombocytopenia, pancytopenia and leukopenia. The dose should be reduced in renal functional impairment.
Paracetamol should be given with care to patients with impaired kidney or liver function.
Paracetamol should be given with care to patients taking other drugs that affect the liver in view of the product's inherent potential to cause fluid retention, heart failure may be precipitated in some compromised patients
Storage instructions:
Store below 25ºC. Protect from moisture. Keep out of reach of children.